IFNA1 and viral infectious disease: RNAi-mediated IFN induction may potently enhance the anti-HBV efficiency of specific siRNAs, and further studies will focus on the in vivo effects of this dual activity approach and how to manipulate RNAi to manage viral infection while inhibiting the immunoenhancing effect of RNAi to prevent unwanted side effects.